PL4027974T3 - Kompozycja farmaceutyczna zawierająca p-boronofenyloalaninę - Google Patents
Kompozycja farmaceutyczna zawierająca p-boronofenyloalaninęInfo
- Publication number
- PL4027974T3 PL4027974T3 PL20781115.9T PL20781115T PL4027974T3 PL 4027974 T3 PL4027974 T3 PL 4027974T3 PL 20781115 T PL20781115 T PL 20781115T PL 4027974 T3 PL4027974 T3 PL 4027974T3
- Authority
- PL
- Poland
- Prior art keywords
- boronophenylalanine
- pharmaceutical composition
- composition containing
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1468—Containers characterised by specific material properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/009—Neutron capture therapy, e.g. using uranium or non-boron material
- A61K41/0095—Boron neutron capture therapy, i.e. BNCT, e.g. using boronated porphyrins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019165835 | 2019-09-12 | ||
| PCT/JP2020/034391 WO2021049599A1 (en) | 2019-09-12 | 2020-09-11 | Pharmaceutical composition containing p-boronophenylalanine and method for producing same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4027974T3 true PL4027974T3 (pl) | 2025-04-28 |
Family
ID=72659849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20781115.9T PL4027974T3 (pl) | 2019-09-12 | 2020-09-11 | Kompozycja farmaceutyczna zawierająca p-boronofenyloalaninę |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220354875A1 (pl) |
| EP (2) | EP4520336A3 (pl) |
| JP (1) | JP7519108B2 (pl) |
| KR (1) | KR20220061953A (pl) |
| CN (1) | CN114144186A (pl) |
| AR (1) | AR119948A1 (pl) |
| AU (1) | AU2020345336B2 (pl) |
| CA (1) | CA3151664A1 (pl) |
| ES (1) | ES3015102T3 (pl) |
| PL (1) | PL4027974T3 (pl) |
| TW (1) | TWI860402B (pl) |
| WO (1) | WO2021049599A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115444857B (zh) * | 2022-08-30 | 2023-08-01 | 安徽丰原药业股份有限公司 | 一种氰化物解毒剂注射液的制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8712430D0 (en) * | 1987-05-27 | 1987-07-01 | Procter & Gamble | Liquid detergent |
| US5157149A (en) | 1991-06-04 | 1992-10-20 | The United States Of America As Represented By The United States Department Of Energy | Enantioselective synthesis of L-(-)-4- boronophenylalanine (L-BPA) |
| US5935944A (en) | 1993-09-10 | 1999-08-10 | Neutron Technology Corporation | Formulation for I.V. administration of the boron delivery drug, boronophenylalanine (BPA) |
| SE9601348D0 (sv) * | 1996-04-10 | 1996-04-10 | Pharmacia Ab | Improved containers for parenteral fluids |
| JP2979139B2 (ja) | 1998-03-11 | 1999-11-15 | 東北大学長 | L−パラボロノフェニルアラニンの製造方法 |
| JP2000212185A (ja) | 1999-01-14 | 2000-08-02 | Ajinomoto Co Inc | パラボロノフェニルアラニン誘導体の製造方法 |
| WO2007046411A1 (ja) * | 2005-10-19 | 2007-04-26 | Dainippon Sumitomo Pharma Co., Ltd. | イソキサゾール化合物の安定化方法 |
| JP5150084B2 (ja) * | 2006-10-17 | 2013-02-20 | 日本ケミカルリサーチ株式会社 | 高水溶性p−ボロノフェニルアラニン含有組成物 |
| DK2080501T3 (en) * | 2006-10-27 | 2015-08-03 | Otsuka Pharma Co Ltd | Package containing drug solution with reduced dissolved oxygen content |
| JP5345771B2 (ja) | 2007-08-27 | 2013-11-20 | 公立大学法人大阪府立大学 | p−ボロノフェニルアラニンとソルビトールとを含有する液状組成物 |
| JP2013173804A (ja) * | 2013-06-14 | 2013-09-05 | Osaka Prefecture Univ | p−ボロノフェニルアラニンとソルビトールとを含有する液状組成物 |
| CN103690470A (zh) * | 2013-07-09 | 2014-04-02 | 四川科伦药业股份有限公司 | 一种医用塑料包装液体制剂及其灭菌方法和制备方法 |
-
2020
- 2020-09-11 JP JP2021570543A patent/JP7519108B2/ja active Active
- 2020-09-11 WO PCT/JP2020/034391 patent/WO2021049599A1/en not_active Ceased
- 2020-09-11 PL PL20781115.9T patent/PL4027974T3/pl unknown
- 2020-09-11 ES ES20781115T patent/ES3015102T3/es active Active
- 2020-09-11 CA CA3151664A patent/CA3151664A1/en active Pending
- 2020-09-11 TW TW109131284A patent/TWI860402B/zh active
- 2020-09-11 EP EP25152531.7A patent/EP4520336A3/en active Pending
- 2020-09-11 KR KR1020227004717A patent/KR20220061953A/ko active Pending
- 2020-09-11 AR ARP200102532A patent/AR119948A1/es not_active Application Discontinuation
- 2020-09-11 CN CN202080053010.5A patent/CN114144186A/zh active Pending
- 2020-09-11 AU AU2020345336A patent/AU2020345336B2/en active Active
- 2020-09-11 EP EP20781115.9A patent/EP4027974B1/en active Active
- 2020-09-11 US US17/636,246 patent/US20220354875A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4027974A1 (en) | 2022-07-20 |
| ES3015102T3 (en) | 2025-04-29 |
| TWI860402B (zh) | 2024-11-01 |
| EP4027974B1 (en) | 2025-02-26 |
| KR20220061953A (ko) | 2022-05-13 |
| CN114144186A (zh) | 2022-03-04 |
| US20220354875A1 (en) | 2022-11-10 |
| JP2022547764A (ja) | 2022-11-16 |
| EP4027974C0 (en) | 2025-02-26 |
| AU2020345336B2 (en) | 2025-12-11 |
| TW202123946A (zh) | 2021-07-01 |
| WO2021049599A1 (en) | 2021-03-18 |
| CA3151664A1 (en) | 2021-03-18 |
| EP4520336A2 (en) | 2025-03-12 |
| AU2020345336A1 (en) | 2022-01-27 |
| EP4520336A3 (en) | 2025-05-07 |
| JP7519108B2 (ja) | 2024-07-19 |
| AR119948A1 (es) | 2022-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB202019241D0 (en) | Pharmaceutical composition | |
| GB201911517D0 (en) | Pharmaceutical composition | |
| GB201807053D0 (en) | Pharmaceutical composition | |
| IL290469A (en) | Oral pharmaceutical preparation | |
| ZA202006541B (en) | Pharmaceutical composition comprising brexpiprazole | |
| HUE064916T2 (hu) | Gyógyászati készítmény | |
| IL285728A (en) | Pharmaceutical composition | |
| PL3949952T3 (pl) | Kompozycja farmaceutyczna | |
| SG11202103374TA (en) | Pharmaceutical composition | |
| PL4027974T3 (pl) | Kompozycja farmaceutyczna zawierająca p-boronofenyloalaninę | |
| GB202208464D0 (en) | Pharmaceutical composition | |
| GB202104224D0 (en) | Pharmaceutical composition | |
| GB202018068D0 (en) | Pharmaceutical composition | |
| GB202010340D0 (en) | Pharmaceutical composition | |
| GB201912686D0 (en) | Pharmaceutical composition | |
| GB201908003D0 (en) | Pharmaceutical composition | |
| IL286162A (en) | Pharmaceutical preparations containing anti-lingo-1 antibodies | |
| GB202109271D0 (en) | Pharmaceutical composition | |
| GB202108387D0 (en) | Pharmaceutical composition | |
| GB202107518D0 (en) | Pharmaceutical composition | |
| GB202105858D0 (en) | Pharmaceutical composition | |
| GB202105462D0 (en) | Pharmaceutical composition | |
| GB202105049D0 (en) | Pharmaceutical composition | |
| GB202105047D0 (en) | Pharmaceutical composition | |
| GB202102100D0 (en) | Pharmaceutical composition |